⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7396679 | 0.67 | — | — | |
| SCHEMBL11045783 | 0.62 | — | — | |
| SCHEMBL22433110 | 0.62 | — | — | |
| SCHEMBL581025 | 0.62 | — | — | |
| SCHEMBL25224708 | 0.59 | — | — | |
| SCHEMBL31758216 | 0.59 | — | — | |
| SCHEMBL16024475 | 0.59 | — | — | |
| SCHEMBL523201 | 0.50 | — | — | |
| SCHEMBL9936611 | 0.48 | — | — | |
| SCHEMBL8857 | 0.46 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3091008-A1 | KINASE INHIBITOR AND USE THEREOF | Xuanzhu Pharma Co., Ltd. (CN) | 2016-11-09 | — | — | EP | disclosed |